Home > News > Nanogen Expands Molecular Diagnostic Product Menu
March 6th, 2003
Nanogen Expands Molecular Diagnostic Product Menu
Abstract:
Nanogen announced today that it has commercially released the first multiplex Analyte Specific Reagent, designed for the detection of Factor V Leiden and Factor II Prothrombin gene mutations associated with cardiovascular disease and the pathology of thrombosis.
Source:
Nanogen
Bookmark:
| Related News Press |
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||